Star Health Targets 15-16% Return on Equity in Concall Update

Market snapshot: Star Health and Allied Insurance Company Limited conducted its Q1 FY27 earnings call, highlighting a focus on sustainable profitability and confirming its target of achieving a 15-16% Return on Equity (ROE) by FY28. The company's raw alert reported a 15-16% insurance revenue growth projection for FY27 (as stated in the source alert; not independently verified), but verified updates show the management is prioritizing ROE and aiming for a Gross Written Premium (GWP) of ₹24,000 crore in FY27.

Data Snapshot

• Standalone Net Profit rose 25.5% year-on-year to ₹550 crore in Q1 FY27 compared to ₹438 crore in Q1 FY26.
• Gross Written Premium grew 19% YoY to ₹4,287 crore, driven by a 37% surge in retail fresh health premiums.
• Underwriting Profit jumped to ₹111 crore in Q1 FY27 from ₹16 crore in the year-ago quarter.
• Combined Insurance Service Ratio improved to 97.0% in Q1 FY27 compared to 98.7% in Q1 FY26.

What's Changed

• Underwriting results have structurally turned around, reversing from a negative ₹165 crore in FY25 to a positive ₹206 crore in FY26, and extending strong gains into Q1 FY27.
• The mandatory transition to Indian Accounting Standards starting April 1, 2026, allows acquisition costs to be deferred, aligning expenses with premium terms to provide clearer margin visibility.

Key Takeaways

• Profitability Momentum: Net profit grew 25.5% YoY to ₹550 crore, reinforcing Star Health's dominant retail market leadership.
• Underwriting Turnaround: Underwriting profit surged nearly seven-fold to ₹111 crore, reflecting selective risk selection and cost discipline.
• Digital Sourcing Dominance: 97% of all fresh retail policies during the quarter were sourced via digital channels, with direct D2C growing 142% YoY.
• Capital Cushion: Solvency ratio remained comfortable at 2.09, well above the regulatory requirement.

SAHI Perspective

Star Health is leveraging its dominant ~33% retail market share to pivot toward a risk-first, profitability-linked growth model rather than pursuing low-margin volume. By adjusting pricing across key portfolios and expanding digital D2C channels, the insurer is effectively controlling acquisition costs. The transition to Ind AS and structural annual price adjustments are critical tools designed to stabilize the claims ratio and secure the management's target of a 15-16% Return on Equity.

Market Implications

Standalone health insurers continue to outperform broader general insurance players, who face combined ratio pressures in commercial lines. Star Health's strong retail health premium expansion highlights resilient consumer demand, positioning the stock favorably amid rising medical inflation.

Trading Signals

Market Bias: Bullish

The 25.5% jump in net profit to ₹550 crore alongside a massive underwriting profit turnaround to ₹111 crore demonstrates strong operating leverage and structural margin expansion.

Overweight: Health Insurance, Financial Services

Trigger Factors:

• Sustainability of 37% retail fresh health premium growth
• Loss ratio trends post-monsoon season
• Progress on digital D2C acquisition costs

Time Horizon: Medium-term (3-12 months)

Industry Context

The Indian standalone health insurance space grew premiums by over 32% YoY in the first quarter of FY27. Rising medical inflation and regulatory revisions to moratorium and waiting periods are driving general premium hikes of 10-15% across the industry, supporting top-line compounding for established players.

Key Risks to Watch

• Medical Inflation: Faster-than-expected rise in healthcare treatment costs could pressure claims and loss ratios.
• Monsoon Seasonality: Historical quarterly claim variations suggest higher claim frequency during monsoon and post-monsoon periods.
• Portability Competition: Aggressive customer acquisition by general insurers via portability-driven growth remains a watchpoint.

Recent Developments

On July 29, 2026, the board of Star Health approved requests from late Rakesh Jhunjhunwala's estate and related shareholders to reclassify certain promoter group entities to the public category. Additionally, the company became India's first health insurer to process over 100 claim transactions through the National Health Claims Exchange (NHCX), optimizing processing timelines.

Closing Insight

Star Health's strategic transition from top-line expansion to margin-led risk selection is successfully yielding bottom-line resilience, setting a clear trajectory to hit its long-term return on equity targets.

High Performance Trading with SAHI.